In this section
New Therapeutics for Respiratory Syncytial Virus (RSV) Disease in Infants and Children
Dr. Kelly J. Henrickson, Director of the Midwest Respiratory Virus Program at Children’s Wisconsin talks us through many details about RSV including the new RSV therapies that are available.
Link to Grand Round Lecture
7:29 Grand Rounds lecture starts
9:20 Disease presentation/history
17:56 Midwest Respiratory Virus Program Surveillance data
22:28 Lab diagnosis for viral respiratory disease is critical
28.28 RSV Risks & Season
32.30 Top 5 Causes of Infant Hospitalization in US
33:48 New RSV vaccines details
47:56 Q & A
If you have a clinical question regarding a case, please contact the Physician Consultation Line (414) 266-2460 or (800) 266-0366.
To refer a patient:
• External referral via Epic
Send to CHW_INFECTIOUS DISEASE CLINIC
• Via fax
To Central Scheduling (414) 607-5288 to Infectious Disease
• Via phone
Central Scheduling at (414) 607-5280